2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC1043
Submitter : Dr. Sue Klein Date & Time: 10/27/2005 10:10:30
Organization : Feminist Majority Foundation
Category : Consumer Group
Issue Areas/Comments
The FDA is loosing credibility with many who had long valued its role in using good scientific evidence to advance and protect our health. It should immediately approve Plan B as recommended by its own panels of advisors and expert civil service staff.

Thank You, Dr. Sue Klein